Table 2 Clinical characteristics of patients with HGSOC by high and low radiomic score group from TCIA-TCGA data.
Characteristic | Total (N = 89) No. (%) | High (N = 51) No. (%) | Low (N = 38) No. (%) | p |
|---|---|---|---|---|
Age | 0.141 | |||
< 59 | 42 (47.2) | 28 (54.9) | 14 (36.8) | |
≥ 60 | 47 (52.8) | 23 (45.1) | 24 (63.2) | |
Radiotherapy | 1 | |||
No | 86 (96.6) | 49 (96.1) | 37 (97.4) | |
Yes | 3 (3.4) | 2 (3.9) | 1 (2.6) | |
Chemotherapy | 0.133 | |||
No | 4 (4.5) | 4 (7.8) | 0 (0) | |
Yes | 85 (95.5) | 47 (92.2) | 38 (100) | |
Lymphatic invasion | 0.411 | |||
No/unknown | 66 (74.2) | 40 (78.4) | 26 (68.4) | |
Yes | 23 (25.8) | 11 (21.6) | 12 (31.6) | |
Venous invasion | 0.853 | |||
No/unknown | 73 (82) | 41 (80.4) | 32 (84.2) | |
Yes | 16 (18) | 10 (19.6) | 6 (15.8) | |
FIGO stage | 0.296 | |||
II/III | 47 (52.8) | 24 (47.1) | 23 (60.5) | |
IV/unknown | 42 (47.2) | 27 (52.9) | 15 (39.5) | |
Tumor residual disease | 0.063 | |||
No/unknown | 32 (36) | 23 (45.1) | 9 (23.7) | |
Yes | 57 (64) | 28 (54.9) | 29 (76.3) | |
Histologic grade | 0.488 | |||
G1/G2 | 9 (10.1) | 4 (7.8) | 5 (13.2) | |
G3/GX | 80 (89.9) | 47 (92.2) | 33 (86.8) | |
